BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 14766824)

  • 1. Laboratory evaluation of a fully automated chemiluminescence immunoassay for rapid detection of HBsAg, antibodies to HBsAg, and antibodies to hepatitis C virus.
    Ismail N; Fish GE; Smith MB
    J Clin Microbiol; 2004 Feb; 42(2):610-7. PubMed ID: 14766824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C.
    Ryu JH; Kwon M; Moon JD; Hwang MW; Lee JM; Park KH; Yun SJ; Bae HJ; Choi A; Lee H; Jung B; Jeong J; Han K; Kim Y; Oh EJ
    Ann Lab Med; 2018 Nov; 38(6):578-584. PubMed ID: 30027702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One or two serological assay testing strategy for diagnosis of HBV and HCV infection? The use of predictive modelling.
    Parry JV; Easterbrook P; Sands AR
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):705. PubMed ID: 29143611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory evaluation of the UniCel DxI 800 analyser (Beckman Coulter) for detecting HBV and HCV serological markers.
    Miedouge M; Legrand-Abravanel F; Lalanne C; Saune K; Izopet J
    J Clin Virol; 2009 Feb; 44(2):134-7. PubMed ID: 19110466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical and laboratory evaluation of a new fully-automated third generation enzyme immunoassay for the detection of antibodies to the hepatitis C virus.
    Bonanni P; Icardi GC; Raffo AM; Ferrari Bravo M; Roccatagliata A; Crovari P
    J Virol Methods; 1996 Dec; 62(2):113-22. PubMed ID: 9002069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of hepatitis B assays on the Bayer ADVIA Centaur Immunoassay System.
    van Helden J; Denoyel G; Karwowska S; Reamer R; Schmalz J; Wright T; Preisel-Simmons B
    Clin Lab; 2004; 50(1-2):63-73. PubMed ID: 15000222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the ADVIA Centaur and Abbott AxSYM immunoassay systems for a routine diagnostic virology laboratory.
    Taylor P; Pickard G; Gammie A; Atkins M
    J Clin Virol; 2004 Apr; 30 Suppl 1():S11-5. PubMed ID: 15062762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations.
    Cruz HM; Scalioni Lde P; de Paula VS; da Silva EF; do Ó KM; Milagres FA; Cruz MS; Bastos FI; Pollo-Flores P; Leal E; Motta-Castro AR; Pilotto JH; Lewis-Ximenez LL; Lampe E; Villar LM
    BMC Infect Dis; 2015 Nov; 15():548. PubMed ID: 26619906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
    Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
    Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of LIAISON® XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24.
    De Paschale M; Manco MT; Belvisi L; Cagnin D; Cerulli T; Paganini A; Arpino O; Cianflone A; Agrappi C; Mirri P; Clerici P
    J Med Virol; 2017 Mar; 89(3):489-496. PubMed ID: 27467710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of rapid diagnostic tests for detection of Hepatitis B and C markers in HIV infected patients.
    Barbosa JR; Colares JKB; Flores GL; Cortes VF; Miguel JC; Portilho MM; Marques VA; Potsch DV; Brandão-Mello CE; Amendola-Pires M; Pilotto JH; Lima DM; Lampe E; Villar LM
    J Virol Methods; 2017 Oct; 248():244-249. PubMed ID: 28782578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
    Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
    Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent developments in serologic and molecular diagnosis of hepatitis B and C].
    Poljak M; Lepej SZ; Rode OD
    Acta Med Croatica; 2013 Oct; 67(4):281-90. PubMed ID: 24984327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus markers in anti-HBc only positive individuals.
    Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
    J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the analytical performance of six rapid diagnostic tests for the detection of viral hepatitis B and C in Lubumbashi, Democratic Republic of Congo.
    Kabamba AT; Mwamba CM; Dessilly G; Dufrasne F; Kabamba BM; Longanga AO
    J Virol Methods; 2020 Nov; 285():113961. PubMed ID: 32860797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
    Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
    J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of two new automated assays for hepatitis B virus surface antigen (HBsAg) detection: IMMULITE HBsAg and IMMULITE 2000 HBsAg.
    Weber B; Dengler T; Berger A; Doerr HW; Rabenau H
    J Clin Microbiol; 2003 Jan; 41(1):135-43. PubMed ID: 12517838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.